Gefitinib is an inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase, used primarily in selected cancers, such as non-small-cell lung cancer. It is marketed under the trade name Iressa.Wikipedia
SNPs associated with gefitinib include: